KALA

Conviction 53HealthcareScan · Mon, Aug 10, 2026

KALA$0.7545+0.90%

ResistanceSupportVol 14

Vol MA14 87.68K

May 11May 28Jun 16Jul 6Jul 23Aug 10

KALA BIO, Inc.PHARMACEUTICAL PREPARATIONSwww.kalarx.com ↗

Price0.7545

Change+0.90%

Gap+9.37%

Rel volume0.73×

Avg volume120.45K

Avg $ vol95.43K

SMA 200.7518

SMA 501.66

SMA 2000.9239

Price vs 50-54.45%

Price vs 200-18.33%

MA stackmixed

50/200 cross—

Supertrenddown · 1.12

RSI (14)35

MACD hist0.06

MACD crossbull · 7d

Stoch %K / %D57 / 54

ADX (14)27

+DI / −DI19 / 24

RSI divergence—

MACD divergence—

ATR %+19.51%

ADR %13.93%

52w high19.63

52w low0.0793

From 52w high-96.16%

Above 52w low+851.45%

New 52w highNo

SqueezeOff

Bollinger width52.09%

%B0.51

Donchian pos29.91%

Donchian high1.14

Donchian low0.5900

AVWAP (52w high)0.8501

vs AVWAP high-11.25%

AVWAP (52w low)1.09

vs AVWAP low-30.98%

OBV trendFlat

Chaikin MF (20)-0.44

Today vs 20d0.73×

Avg vol (14d)87.68K

Avg vol (20d)120.45K

Avg $ vol (20d)95.43K

Market cap14.03M

RS 3m (vs SPY)+794.18%

RS 6m (vs SPY)+73.30%

RS line new highNo

Trend template4/8

Technical rank38.1

1 week-3.64%

1 month-35.79%

3 months+851.45%

6 months+71.48%

1 year-89.46%

YTD+21.48%

P/E-0.52

P/B1.30

P/S—

P/FCF-0.42

EPS-3.31

Div yield—

ROE-250.72%

ROA-219.03%

Debt/Eq4.39

Current7.91

EV/EBITDA-1.53

Gross margin—

Net margin—

Rev growth—

EPS growth29.94%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value59.46M

Revenue—

Net income-1.62M

Gross profit—

Free cash flow-33.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out18.59M

Employees6

ListedThu, Jul 20, 2017

Free float796.55M

Float %83.4%

Short interest256.62K

Days to cover1.2d

Short volume51.9%

Squeeze score14 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank38.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.87

Support0.6425

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KALA

All disclosures →

No recent disclosed trades by Congress in KALA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KALA

No recent insider (Form 4) filings in KALA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in KALA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.